Sfoglia per Autore
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion.
2008 E.Rovida; E.Spinelli E; S.Sdelci; V.Barbetti; A.Morandi; S.Giuntoli; P.Dello Sbarba.
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells
2008 Barbetti V, Gozzini A, Rovida E, Morandi A, Spinelli E, Fossati G, Mascagni P, Lübbert M, Dello Sbarba P, Santini V.
Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance
2010 Plaza-Menacho, I; Morandi, A; Robertson, D; Pancholi, S; Drury, S; Dowsett, M; Martin, L-A; Isacke, C M
RET in breast cancer: functional and therapeutic implications
2011 Morandi, Andrea; Plaza-Menacho, Ivan; Isacke, Clare M
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines.
2011 A.Morandi;V.Barbetti;M.Riverso;P.Dello Sbarba;E.Rovida
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism
2011 Plaza-Menacho, Iván; Morandi, Andrea; Mologni, Luca; Boender, Piet; Gambacorti-Passerini, Carlo; Magee, Anthony I; Hofstra, Robert M W; Knowles, Phillip; McDonald, Neil Q; Isacke, Clare M
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase
2013 Mologni, Luca; Redaelli, Sara; Morandi, Andrea; Plaza-Menacho, Ivan; Gambacorti-Passerini, Carlo
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors
2013 Morandi, Andrea; Martin, Lesley-Ann; Gao, Qiong; Pancholi, Sunil; Mackay, Alan; Robertson, David; Zvelebil, Marketa; Dowsett, Mitch; Plaza-Menacho, Ivan; Isacke, Clare M
Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer
2014 Morandi, Andrea; Isacke, Clare M
Senescent stroma promotes prostate cancer progression: The role of miR-210
2014 Taddei ML; Cavallini L; Comito G; Giannoni E; Folini M; Marini A; Gandellini P; Morandi A; Pintus G; Raspollini MR; Zaffaroni N; Chiarugi P.
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation
2014 Rapizzi E; Ercolino T; Fucci R; Zampetti B; Felici R; Guasti D; Morandi A; Giannoni E; Giaché V; Bani D; Chiarugi A; Mannelli M
Metabolic implication of tumor:stroma crosstalk in breast cancer.
2014 Morandi A; Chiarugi P
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.
2014 Barbetti V; Morandi A; Tusa I; Digiacomo G; Riverso M; Marzi I; Cipolleschi MG; Bessi S; Giannini A; Di Leo A; Dello Sbarba P; Rovida E.
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells
2014 Taddei ML; Giannoni E; Morandi A; Ippolito L; Ramazzotti M; Callari M; Gandellini P; Chiarugi P
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
2015 Giannoni, E; Taddei, Ml; Morandi, A; Comito, G; Calvani, M; Bianchini, F; Richichi, B; Raugei, G; Wong, N; Tang, D; Chiarugi, P.
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
2016 Kowalik, Marta Anna; Guzzo, Giulia; Morandi, Andrea; Perra, Andrea; Menegon, Silvia; Masgras, Ionica; Trevisan, Elena; Angioni, Maria Maddalena; Fornari, Francesca; Quagliata, Luca; Ledda-Columbano, Giovanna Maria; Gramantieri, Laura; Terracciano, Luigi; Giordano, Silvia; Chiarugi, Paola; Rasola, Andrea; Columbano, Amedeo
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival
2016 Mattu, Sandra; Fornari, Francesca; Quagliata, Luca; Perra, Andrea; Angioni, Maria Maddalena; Petrelli, Annalisa; Menegon, Silvia; Morandi, Andrea; Chiarugi, Paola; Ledda-Columbano, Giovanna Maria; Gramantieri, Laura; Terracciano, Luigi; Giordano, Silvia; Columbano, Amedeo
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
2016 Ippolito, Luigi; Marini, Alberto; Cavallini, Lorenzo; Morandi, Andrea; Pietrovito, Laura; Pintus, Gianfranco; Giannoni, Elisa; Schrader, Thomas; Puhr, Martin; Chiarugi, Paola; Taddei, Maria Letizia
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts
2016 Andreucci, Elena; Francica, Paola; Fearns, Antony; Martin, Lesley-Ann; Chiarugi, Paola; Isacke, Clare M; Morandi, Andrea
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
2016 Morandi, A; Giannoni, E.; Chiarugi, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. | 2008 | E.Rovida; E.Spinelli E; S.Sdelci; V.Barbetti; A.Morandi; S.Giuntoli; P.Dello Sbarba. | |
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells | 2008 | Barbetti V, Gozzini A, Rovida E, Morandi A, Spinelli E, Fossati G, Mascagni P, Lübbert M, Dello Sbarba P, Santini V. | |
Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance | 2010 | Plaza-Menacho, I; Morandi, A; Robertson, D; Pancholi, S; Drury, S; Dowsett, M; Martin, L-A; Isacke, C M | |
RET in breast cancer: functional and therapeutic implications | 2011 | Morandi, Andrea; Plaza-Menacho, Ivan; Isacke, Clare M | |
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. | 2011 | A.Morandi;V.Barbetti;M.Riverso;P.Dello Sbarba;E.Rovida | |
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism | 2011 | Plaza-Menacho, Iván; Morandi, Andrea; Mologni, Luca; Boender, Piet; Gambacorti-Passerini, Carlo; Magee, Anthony I; Hofstra, Robert M W; Knowles, Phillip; McDonald, Neil Q; Isacke, Clare M | |
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase | 2013 | Mologni, Luca; Redaelli, Sara; Morandi, Andrea; Plaza-Menacho, Ivan; Gambacorti-Passerini, Carlo | |
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors | 2013 | Morandi, Andrea; Martin, Lesley-Ann; Gao, Qiong; Pancholi, Sunil; Mackay, Alan; Robertson, David; Zvelebil, Marketa; Dowsett, Mitch; Plaza-Menacho, Ivan; Isacke, Clare M | |
Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer | 2014 | Morandi, Andrea; Isacke, Clare M | |
Senescent stroma promotes prostate cancer progression: The role of miR-210 | 2014 | Taddei ML; Cavallini L; Comito G; Giannoni E; Folini M; Marini A; Gandellini P; Morandi A; Pintus G; Raspollini MR; Zaffaroni N; Chiarugi P. | |
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation | 2014 | Rapizzi E; Ercolino T; Fucci R; Zampetti B; Felici R; Guasti D; Morandi A; Giannoni E; Giaché V; Bani D; Chiarugi A; Mannelli M | |
Metabolic implication of tumor:stroma crosstalk in breast cancer. | 2014 | Morandi A; Chiarugi P | |
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. | 2014 | Barbetti V; Morandi A; Tusa I; Digiacomo G; Riverso M; Marzi I; Cipolleschi MG; Bessi S; Giannini A; Di Leo A; Dello Sbarba P; Rovida E. | |
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells | 2014 | Taddei ML; Giannoni E; Morandi A; Ippolito L; Ramazzotti M; Callari M; Gandellini P; Chiarugi P | |
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread | 2015 | Giannoni, E; Taddei, Ml; Morandi, A; Comito, G; Calvani, M; Bianchini, F; Richichi, B; Raugei, G; Wong, N; Tang, D; Chiarugi, P. | |
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis | 2016 | Kowalik, Marta Anna; Guzzo, Giulia; Morandi, Andrea; Perra, Andrea; Menegon, Silvia; Masgras, Ionica; Trevisan, Elena; Angioni, Maria Maddalena; Fornari, Francesca; Quagliata, Luca; Ledda-Columbano, Giovanna Maria; Gramantieri, Laura; Terracciano, Luigi; Giordano, Silvia; Chiarugi, Paola; Rasola, Andrea; Columbano, Amedeo | |
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival | 2016 | Mattu, Sandra; Fornari, Francesca; Quagliata, Luca; Perra, Andrea; Angioni, Maria Maddalena; Petrelli, Annalisa; Menegon, Silvia; Morandi, Andrea; Chiarugi, Paola; Ledda-Columbano, Giovanna Maria; Gramantieri, Laura; Terracciano, Luigi; Giordano, Silvia; Columbano, Amedeo | |
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. | 2016 | Ippolito, Luigi; Marini, Alberto; Cavallini, Lorenzo; Morandi, Andrea; Pietrovito, Laura; Pintus, Gianfranco; Giannoni, Elisa; Schrader, Thomas; Puhr, Martin; Chiarugi, Paola; Taddei, Maria Letizia | |
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts | 2016 | Andreucci, Elena; Francica, Paola; Fearns, Antony; Martin, Lesley-Ann; Chiarugi, Paola; Isacke, Clare M; Morandi, Andrea | |
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk | 2016 | Morandi, A; Giannoni, E.; Chiarugi, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile